Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 2 Demographic data for the 15 patients included in the series

From: Clinical and functional outcomes of the saddle prosthesis

Patient

Gender

Age

Implant

Side

Diagnosis

Local rec./mo

Patient follow-up (months)

Follow-up of the implant (months)

Status

Postoperative leg length discrepancy (cm)

Shortening at follow-up (cm)

Outcome

1

m

39

Primary

R

Chs

Yes/24

62

28

dec

+2

Not evaluable

Hind quarter amputation after 28 months for local recurrence, flail hip

2

m

57

Primary

L

Os

No

60

2

ned

+2

Not evaluable

Hind quarter amputation after 2 months for deep infection

3

m

40

Primary

L

Fs

No

25

25

dec

+1.5

Not evaluable

Early death from disease progression

4a

m

47

Primary

L

Chs

No

167

167

ned

+2

−0.5

Saddle was in site but dislocated after gait analysis was performed

5

f

56

Primary

L

Chs

No

75

75

ned

+4

Not evaluable

Deep infection occurred after 36 months; the patient refused further surgery and was treated with chronic antibiotic suppression

6

m

61

Secondary

R

Chs dediff

No

124

108

ned

0

−5

Saddle removed after 108 months for chronic pain, flail hip

7a

m

59

Primary

L

Chs

No

136

136

ned

0

−2.5

Saddle in site

8

m

23

Secondary

L

Os

No

126

126

ned

+1

−2.5

Saddle in site

9

m

47

Primary

R

Chs dediff

Yes/6

24

8

dec

+3

Not evaluable

Hind quarter amputation after 8 months for local recurrence

10

m

58

Primary

L

Chs

No

120

120

ned

+1.5

−3

Saddle in site

11

m

40

Secondary

R

Gct

No

101

101

ned

0

−1.5

Saddle in site

12

m

51

Primary

R

Os

No

97

97

ned

+1

−3.5

Saddle in site

13

f

25

Secondary

L

Os

No

6

6

dec

+1

Not evaluable

Early death from disease progression

14

m

79

Primary

L

Chs

No

9

3

dec

+2

Not evaluable

Hind quarter amputation after 3 months due to deep infection

15

f

68

Secondary

R

Chs

No

78

38

ned

+1.5

−2.5

Saddle removed after 38 months for chronic pain, flail hip

Range

23–79

    

6–167

2–167

 

0–4

−0.5 to −5

 

Mean

50

    

81

69

 

+1.5

−2.6

 

SD

15

    

50

56

 

1.1

1.3

 
  1. Os osteosarcoma, Gct giant cell tumor, Chs chondrosarcoma, Chs dediff chondrosarcoma dedifferentiated, Fs fibrosarcoma, dec dead, ned still alive
  2. aPatients 7 and 4 were evaluated using gait analysis 75 and 60 months after the index operation